Aditum Bio
Adam Fowler is an accomplished biotechnology professional with extensive experience in the biopharmaceutical industry. Currently serving as Vice President of Biologics CMC at Aditum Bio, Adam has held key leadership roles including Senior Vice President of Technical Operations at Locanabio, Inc. and Senior Director of Pharmaceutical Development & Manufacturing at both Bristol Myers Squibb and Celgene. Additionally, Adam is the President and Principal Consultant at Precision CMC BioProcess Consulting. Adam holds both a Master of Science and a Bachelor of Science in Biotechnology from Worcester Polytechnic Institute.
This person is not in the org chart
This person is not in any offices
Aditum Bio
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets. It gives patients access to medicines that may not otherwise be developed. Aditum Bio was founded on 2019 and is headquartered in San Francisco, California.